Quantum Leap Healthcare Collaborative
Radhika Sivaramakrishna, PhD, PMP, CSSBB, CCRP has a diverse work experience in various leadership and consulting roles in the healthcare and pharmaceutical industries. Radhika is currently the Senior Vice President of Clinical Operations and Compliance at Quantum Leap Healthcare Collaborative, where they oversee clinical operations and ensures compliance. Prior to this, they were the Senior Vice President of Program Management at Grace Science, LLC, where they managed program delivery. Radhika also co-owned Numeric Insight, Inc., a consulting firm, and served as the Vice President of Project Delivery at Clinical Maestro by Strategikon Pharma. Radhika has extensive experience in project and portfolio management, business process improvement, and clinical operations. Radhika has held executive positions at BioClin Therapeutics, Dynavax Technologies, and Covance, where they led cross-functional teams and managed external collaborations. Radhika has also served on the Board of Directors at SoCRA, a professional association for clinical research professionals.
Radhika Sivaramakrishna, PhD, PMP, CSSBB, CCRP has an extensive education history in the field of biomedical engineering. Radhika obtained their Bachelor of Science degree in Physics from the University of Madras, where they studied from 1985 to 1988. Following this, they pursued a Masters in Engineering from the Indian Institute of Science (IISc) between 1988 and 1992, specializing in Biomedical Engineering. Radhika's academic pursuits continued at the University of Manitoba, where they earned their Ph.D. in Biomedical Engineering from 1993 to 1997.
Quantum Leap Healthcare Collaborative
A 501C(3) charitable organization, Quantum Leap was established in 2005 as a collaboration between medical researchers at University of California, San Francisco and Silicon Valley entrepreneurs. Our mission is to integrate high-impact research with clinical processes and systems technology, resulting in improved data management and information systems, greater access to clinical trial matching and sponsorship, and greater benefit to providers, patients and researchers. Our goal is to improve and save lives. The founders of Quantum Leap recognize that good ideas and research projects in a University setting were often “orphaned” at the end of a research project. These efforts were frequently left with no funds or organizational structure to adequately engage clinical providers and ultimately benefit patient care. In addition, the intellectual property often created as part of these research endeavors remain untapped and undeveloped. Modeled after Silicon Valley’s entrepreneurial culture with an added social value objective, our social-entrepreneurial model embodies: + Identifying clinical and research efforts with a potential for high impact + Providing financial and managerial assistance + Forming organizations and management teams to grow proven ideas into products + Securing funding in stages as efforts mature + Creating strategic partnerships committed to developing high-value healthcare services and products We support the development and implementation of innovative ways to deliver better, less costly healthcare. We are committed to establishing unique collaborations across the medical, technology and bioscience industries: all necessary components to accelerate healthcare research into the marketplace. Our efforts focus on quality-of-care and quality-of-life issues, and to create initiatives that foster excellent clinical practices using quality improvement disciplines with a strong patient-centric focus.